Natalya Martin
Principal Scientist Sanofi
Natalya Martin, PhD, has over 10 years of experience in the pharmaceutical industry supporting analytical development activities across several different modalities (mRNA vaccines, gene therapy, biologics). She has spent the last 2 years as a Principal Scientist in Analytical Development at Sanofi’s mRNA Centre of Excellence supporting mRNA vaccine development.
Seminars
Tuesday 7th April 2026
Fireside Chat: Bridging In Vitro/In Vivo Translation by Overcoming Limitations of Potency Assays & Animal Models to Accelerate Clinic Progress
2:30 pm
- What key factors should guide the selection of cell lines to develop bioassays that best predict in vivo LNP potency?
- How to design quantitative assays that measure relevant payload expression levels for understanding biological activity?
- Which animal models provide the most reliable assessment of LNP potency and how to better address variability in biodistribution and protein corona formation between species?
Wednesday 8th April 2026
Employing High Throughput, Semi-Automated Analytical Strategies to Accelerate LNP Formulation Optimization
2:45 pm
- The implementation of high throughput lipid content analysis to evaluate new LNP formulations
- The use of automation to streamline sample preparation and increase testing capacity without compromising data quality
- The use of 3D printing technology to accelerate automation development timelines
NEW DATA
